Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;43(7):1111-1123.
doi: 10.1161/ATVBAHA.122.318892. Epub 2023 May 25.

Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping

Affiliations
Review

Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping

Enrico Maiorino et al. Arterioscler Thromb Vasc Biol. 2023 Jul.

Abstract

The complex landscape of cardiovascular diseases encompasses a wide range of related pathologies arising from diverse molecular mechanisms and exhibiting heterogeneous phenotypes. This variety of manifestations poses significant challenges in the development of treatment strategies. The increasing availability of precise phenotypic and multiomics data of cardiovascular disease patient populations has spurred the development of a variety of computational disease subtyping techniques to identify distinct subgroups with unique underlying pathogeneses. In this review, we outline the essential components of computational approaches to select, integrate, and cluster omics and clinical data in the context of cardiovascular disease research. We delve into the challenges faced during different stages of the analysis, including feature selection and extraction, data integration, and clustering algorithms. Next, we highlight representative applications of subtyping pipelines in heart failure and coronary artery disease. Finally, we discuss the current challenges and future directions in the development of robust subtyping approaches that can be implemented in clinical workflows, ultimately contributing to the ongoing evolution of precision medicine in health care.

Keywords: algorithms; coronary artery disease; heart failure; multiomics; precision medicine.

PubMed Disclaimer

Conflict of interest statement

Disclosures None.

Figures

Figure 1.
Figure 1.
(Top) Path towards precision medicine, from one-size-fits-all medicine to individually tailored medicine; (Bottom) Basic workflow of computational disease subtyping applications.

Similar articles

Cited by

References

    1. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392:1736–1788. doi: 10.1016/S0140-6736(18)32203-7 - DOI - PMC - PubMed
    1. Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M. Cost of cardiovascular diseases in the United Kingdom. Heart. 2006;92:1384–1389. doi: 10.1136/hrt.2005.072173 - DOI - PMC - PubMed
    1. Hwang TJ, Lauffenburger JC, Franklin JM, Kesselheim AS. Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012. JACC Basic Transl Sci. 2016;1:301–308. doi: 10.1016/j.jacbts.2016.03.012 - DOI - PMC - PubMed
    1. Mukherjee D, Topol EJ. Pharmacogenomics in cardiovascular diseases. Prog Cardiovasc Dis. 2002;44:479–498. doi: 10.1053/pcad.2002.123467 - DOI - PubMed
    1. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. New England Journal of Medicine. 1994;330:956–961. doi: 10.1056/NEJM199404073301402 - DOI - PubMed

Publication types